loading page

Microbiota driven macrophage mediators in pathogenesis and treatment of gut leakage: current strategies and future perspectives
  • Rani Samsudin,
  • Balachandar Selvakumar,
  • Priyadharshini Sekar
Rani Samsudin
University of Sharjah

Corresponding Author:[email protected]

Author Profile
Balachandar Selvakumar
University of Sharjah
Author Profile
Priyadharshini Sekar
University of Sharjah
Author Profile

Abstract

Macrophages play key roles in tissue homeostasis, defense, disease and repair. Macrophages are highly plastic and exhibit distinct functional phenotypes based on micro-environmental stimuli. Despite several advancements in understanding macrophage biology and their different functional phenotypes in various physiological and pathological conditions, currently available treatment strategies targeting macrophages are limited. Macrophages' high plasticity and diverse functional roles -- including tissue injury and wound healing mechanisms -- mark them as potential targets to mine for efficient therapeutics to treat diseases. Despite mounting evidence on association of gut leakage with several extra-intestinal diseases, there is no targeted standard therapy to treat gut leakage. Therefore, there is an urgent need to develop therapeutic strategies to treat this condition. Macrophages are the cells that play the largest role in interacting with the gut microbiota in the intestinal compartment and exert their intended functions in injury and repair mechanisms. In this review, we have summarized the current knowledge on the origins and phenotypes of macrophages. The specific role of macrophages in intestinal barrier function, their role in tissue repair mechanisms and their association with gut microbiota are discussed. In addition, currently available therapies and the putative tissue repair mediators of macrophages for treating microbiota dysbiosis induced gut leakage are also discussed. The overall aim of this review is to convey the intense need to screen for microbiota induced macrophage-released pro-repair mediators, which could lead to the identification of potential candidates that could be developed for treating the leaky gut and associated diseases.